Biomarin Pharmaceutical reported $6.06B in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
Acorda Therapeutics ACOR:US $ 424.14M 31.33M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amgen AMGN:US $ 59196M 1969M
Bayer BAYN:GR € 125782M 5541M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Gilead Sciences GILD:US $ 63080M 4872M
Insmed INSM:US $ 1.15B 90.19M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Moderna Inc MRNA:US 27.61B 2.94B
Ptc Therapeutics PTCT:US $ 1799.59M 138.46M
Puma Biotechnology PBYI:US $ 200.68M 25.9M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
United Therapeutics UTHR:US $ 5359.8M 190.7M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
YTE INCY:US $ 5054.22M 120.87M